Celldex Therapeutics, Inc. Gains 60.54%
Wed, Jun 10, 2020 at 05:33 PM
Celldex Therapeutics, Inc. (CLDX:NASDAQ) shot up at $4.8, a gain of 60.5%. The stock got featured on our News Catalysts scanner on Tue 09 Jun 20 at 11:04 AM in the 'PATNERSHIP' category. From Tue 26 May 20, the stock recorded 50.00% Up Days and 63.64% Green Days
The share price of the company has been moving sideways in recent weeks.
About Celldex Therapeutics, Inc. (CLDX:NASDAQ)
Celldex Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the development and commercialization of immunotherapy technologies for the treatment of cancer and other difficult-to-treat diseases.
Top 10 Gainers:
- Wins Finance Holdings Inc. (WINS:NASDAQ), 170.8%
- DPW Holdings, Inc. (DPW:NYSEMKT), 114.79%
- Jiayin Group Inc. (JFIN:NASDAQ), 96.61%
- TDH Holdings, Inc. (PETZ:NASDAQ), 82.61%
- Celldex Therapeutics, Inc. (CLDX:NASDAQ), 60.54%
- Inuvo, Inc. (INUV:NYSEMKT), 55.1%
- American Virtual Cloud Technologies, Inc. (AVCT:NASDAQ), 54.13%
- China Finance Online Co. Limited (JRJC:NASDAQ), 51.52%
- Mercurity Fintech Holding Inc. (MFH:NASDAQ), 50%
- Ideal Power Inc. (IPWR:NASDAQ), 47.6%